1. Home
  2. TG vs IPHA Comparison

TG vs IPHA Comparison

Compare TG & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TG
  • IPHA
  • Stock Information
  • Founded
  • TG 1988
  • IPHA 1999
  • Country
  • TG United States
  • IPHA France
  • Employees
  • TG N/A
  • IPHA N/A
  • Industry
  • TG Metal Fabrications
  • IPHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TG Industrials
  • IPHA Health Care
  • Exchange
  • TG Nasdaq
  • IPHA Nasdaq
  • Market Cap
  • TG 172.5M
  • IPHA 171.6M
  • IPO Year
  • TG 1989
  • IPHA 2019
  • Fundamental
  • Price
  • TG $6.91
  • IPHA $2.25
  • Analyst Decision
  • TG
  • IPHA Strong Buy
  • Analyst Count
  • TG 0
  • IPHA 1
  • Target Price
  • TG N/A
  • IPHA $11.50
  • AVG Volume (30 Days)
  • TG 67.2K
  • IPHA 6.4K
  • Earning Date
  • TG 11-07-2024
  • IPHA 09-12-2024
  • Dividend Yield
  • TG N/A
  • IPHA N/A
  • EPS Growth
  • TG N/A
  • IPHA N/A
  • EPS
  • TG N/A
  • IPHA N/A
  • Revenue
  • TG $701,507,000.00
  • IPHA $36,202,722.00
  • Revenue This Year
  • TG N/A
  • IPHA N/A
  • Revenue Next Year
  • TG N/A
  • IPHA $105.84
  • P/E Ratio
  • TG N/A
  • IPHA N/A
  • Revenue Growth
  • TG N/A
  • IPHA N/A
  • 52 Week Low
  • TG $3.98
  • IPHA $1.81
  • 52 Week High
  • TG $7.03
  • IPHA $3.15
  • Technical
  • Relative Strength Index (RSI)
  • TG 74.24
  • IPHA 49.51
  • Support Level
  • TG $5.93
  • IPHA $2.22
  • Resistance Level
  • TG $7.03
  • IPHA $2.29
  • Average True Range (ATR)
  • TG 0.19
  • IPHA 0.13
  • MACD
  • TG 0.06
  • IPHA -0.01
  • Stochastic Oscillator
  • TG 80.77
  • IPHA 48.09

About TG Tredegar Corporation

Tredegar Corp through its subsidiaries engaged in the manufacture of Polyethylene Plastic films, Polyester Films, and Aluminum Extrusions. Polyethylene Plastic films manufacture plastic films, elastics and laminate materials which are utilized in personal care materials, surface protection films, and specialty and optical lighting applications. It operates through PE Films, Flexible Packaging Films, and Aluminum Extrusions segments. Aluminum Extrusions generates the majority of revenue and produces high-quality, soft-alloy, and medium-strength aluminum use for building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. It generates revenue from the United States, Asia, and Brazil.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: